Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors

MLA

Virna Marin, et al. “Cytokine-Induced Killer Cells for Cell Therapy of Acute Myeloid Leukemia: Improvement of Their Immune Activity by Expression of CD33-Specific Chimeric Receptors.” Haematologica, vol. 95, no. 12, Dec. 2010. EBSCOhost, https://doi.org/10.3324/haematol.2010.026310.

APA

Virna Marin, Irene Pizzitola, Valentina Agostoni, Greta Maria Paola Giordano Attianese, Helene Finney, Alastair Lawson, Martin Pule, Raphael Rousseau, Andrea Biondi, & Ettore Biagi. (2010). Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica, 95(12). https://doi.org/10.3324/haematol.2010.026310

Chicago

Virna Marin, Irene Pizzitola, Valentina Agostoni, Greta Maria Paola Giordano Attianese, Helene Finney, Alastair Lawson, Martin Pule, Raphael Rousseau, Andrea Biondi, and Ettore Biagi. 2010. “Cytokine-Induced Killer Cells for Cell Therapy of Acute Myeloid Leukemia: Improvement of Their Immune Activity by Expression of CD33-Specific Chimeric Receptors.” Haematologica 95 (12). doi:10.3324/haematol.2010.026310.